Why UBS's Bearish Outlook and Toxic Debt Make Shorting UBS Shares a Viable Strategy

The Challenges Faced by UBS

I have been closely monitoring the recent events surrounding UBS Group, particularly its first-quarter results and the impending takeover of Credit Suisse. With profits halving due to toxic debt and a challenging economic outlook, I argue that shorting UBS shares presents a viable investment strategy.

The Impact of Toxic Debt on UBS

UBS reported a 52% decline in quarterly income as it set aside an additional $665 million to cover litigation costs related to toxic US residential mortgage-backed securities, dating back to the global financial crisis. This toxic debt has not only impacted the bank's profits but also highlights the vulnerability it faces as it prepares to take over its fallen rival, Credit Suisse.

The Challenges of Acquiring Credit Suisse

The acquisition of $Credit Suisse Group AG(CS)$  adds another layer of complexity and risk to UBS's current challenges. Already struggling with its legacy issues, UBS will now have to deal with the backlash against the deal in Switzerland and absorb Credit Suisse's substantial losses. Credit Suisse reported a $68 billion outflow of assets in the first quarter, with outflows continuing, indicating the magnitude of the task ahead for UBS.

Integration of Credit Suisse:A Herculean Task

UBS's CEO, Sergio Ermotti, acknowledged the "hard" task of integrating Credit Suisse,

Estimating that the process could take four years. During this period, UBS will need to navigate a challenging economic landscape while also dealing with the fallout from its toxic debt and the Credit Suisse takeover. Furthermore, UBS expects customer activity to "remain subdued in the second quarter," though higher interest rates could provide some relief to lending income.

Declining Revenues in Key Divisions

The bank's investment division saw a 19% decline in revenue year-on-year, while profit before tax slumped by 49%. These figures underline the financial strain on UBS and suggest that the short-term outlook for the bank is grim.

Strong Inflows: A Silver Lining?

Despite these challenges, UBS reported strong inflows, with $42 billion in new money, with $28 billion going to its wealth management division. While this could be seen as a positive sign, UBS noted that some clients had shifted to lower-margin products, leading to a slight decrease in year-on-year profit before tax and revenue for the division.

Conclusion: Shorting UBS Shares as a Viable Strategy

In conclusion, UBS is currently grappling with multiple challenges, including toxic debt, a bearish economic outlook, and the complex acquisition of Credit Suisse. The bank's vulnerability is evident in its halved profits, subdued customer activity, and declining revenues across key divisions. Therefore, I believe that shorting UBS shares presents a viable investment strategy for those who anticipate that the bank's struggles will continue in the foreseeable future.

A Word of Caution: Assessing Risks

Investors should, however, carefully consider their risk tolerance and closely monitor UBS's progress in addressing its legacy issues, the integration of Credit Suisse, and its ability to adapt to the economic landscape. It's important to keep in mind that shorting stocks comes with its own set of risks and is not suitable for everyone.

Follow me for more daily post @Jerry Ong https://tigr.link/1ZXrLu

@TigerTalks @TigerBrokers @TigerWire

Disclaimer: The views expressed in this article represent the personal views of myself (the author)and do not constitute investment advice for anyone. The author does not guarantee the accuracy, completeness and timeliness of the information in the article, nor does it assume responsibility for any losses arising from the use of, or reliance on, the information in the article. The author assumes no fiduciary responsibility or liability for any consequences